Evaluating the Antihyperalgesic Potential of Sildenafil–Metformin Combination and Its Impact on Biochemical Markers in Alloxan-Induced Diabetic Neuropathy in Rats

(1) Background: Globally, about 600 million people are afflicted with diabetes, and one of its most prevalent complications is neuropathy, a debilitating condition. At the present time, the exploration of novel therapies for alleviating diabetic-neuropathy-associated pain is genuinely captivating, c...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ciprian Pușcașu, Simona Negreș, Cristina Elena Zbârcea, Anca Ungurianu, Emil Ștefănescu, Nicoleta Mirela Blebea, Cornel Chiriță
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2024-06-01
Sarja:	Pharmaceuticals
Aiheet:	diabetic neuropathy sildenafil metformin antihyperalgesic IL-6 TNF-α
Linkit:	https://www.mdpi.com/1424-8247/17/6/783
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!